Q4 2024 |
196 |
$1.27B |
+$217M |
-$174M |
+$43.1M |
SPY, BAC, JPM, CSCO, COLD
|
13F-HR |
2/12/2025, 08:58 AM |
Q3 2024 |
201 |
$1.25B |
+$231M |
-$178M |
+$52.3M |
SPY, BAC, JPM, CSCO, CMC
|
13F-HR |
11/1/2024, 11:12 AM |
Q2 2024 |
197 |
$1.14B |
+$143M |
-$286M |
-$144M |
SPY, BAC, JPM, CMC, EFC
|
13F-HR |
7/25/2024, 04:16 PM |
Q1 2024 |
202 |
$1.31B |
+$491M |
-$206M |
+$284M |
SPY, JPM, CMC, EFC, BAC
|
13F-HR |
5/3/2024, 03:30 PM |
Q4 2023 |
190 |
$934M |
+$135M |
-$185M |
-$49.4M |
JPM, CMC, CTRA, CNO, CSCO
|
13F-HR |
2/14/2024, 02:25 PM |
Q3 2023 |
208 |
$909M |
+$108M |
-$314M |
-$206M |
CSCO, JPM, CMC, CTRA, VTRS
|
13F-HR |
11/13/2023, 04:04 PM |
Q2 2023 |
211 |
$1.13B |
+$128M |
-$188M |
-$60.4M |
VTRS, CSCO, JPM, VZ, GS
|
13F-HR |
11/13/2023, 04:01 PM |
Q1 2023 |
207 |
$1.14B |
+$184M |
-$196M |
-$12.5M |
CSCO, VTRS, D, VZ, GS
|
Restatement |
11/13/2023, 03:59 PM |
Q4 2022 |
211 |
$1.16B |
+$180M |
-$197M |
-$17M |
TFC, BIO, D, CSCO, VTRS
|
Restatement |
11/13/2023, 03:05 PM |
Q3 2022 |
188 |
$1.05B |
+$119M |
-$90.8M |
+$28.3M |
TFC, GS, D, MRK, PXD
|
13F-HR |
11/9/2022, 08:04 AM |
Q2 2022 |
183 |
$1.12B |
+$192M |
-$134M |
+$57.6M |
GS, UL, TFC, PFE, D
|
13F-HR |
8/10/2022, 09:46 AM |
Q1 2022 |
183 |
$1.32B |
+$227M |
-$210M |
+$16.6M |
CSCO, T, PFE, D, GS
|
13F-HR |
5/13/2022, 05:16 PM |
Q4 2021 |
187 |
$1.37B |
+$273M |
-$444M |
-$171M |
CSCO, UL, GS, DD, NCR
|
Restatement |
8/2/2022, 09:46 AM |
Q3 2021 |
274 |
$1.48B |
$0 |
$0 |
|
CSCO, MRK, DD, GS, BRKB
|
New Holdings |
11/15/2021, 05:40 PM |
Q3 2021 |
274 |
$1.48B |
+$768M |
-$117M |
+$651M |
CSCO, MRK, DD, GS, BRKB
|
13F-HR |
11/1/2021, 02:59 PM |
Q2 2021 |
187 |
$852M |
+$163M |
-$189M |
-$25.6M |
MRK, GM, DD, GS, C
|
Restatement |
7/27/2021, 11:19 AM |
Q1 2021 |
182 |
$835M |
+$176M |
-$167M |
+$9.64M |
GM, MRK, CNP, DD, IP
|
13F-HR |
5/11/2021, 11:11 AM |
Q4 2020 |
131 |
$723M |
+$137M |
-$2.21B |
-$2.07B |
GM, PRMW, ADM, MS, ABBV
|
13F-HR |
2/16/2021, 01:40 PM |
Q3 2020 |
96 |
$2.08B |
+$640M |
-$117M |
+$523M |
INTC, ABBV, DD, GM, BRKB
|
13F-HR |
11/16/2020, 04:00 PM |
Q2 2020 |
93 |
$2.2B |
+$485M |
-$871M |
-$387M |
ABBV, INTC, ADM, BRKB, ETN
|
13F-HR |
8/14/2020, 09:57 AM |
Q1 2020 |
79 |
$2.26B |
+$472M |
-$270M |
+$202M |
ABBV, THS, CNP, INTC, ADM
|
13F-HR |
5/13/2020, 12:14 PM |
Q4 2019 |
79 |
$3.56B |
+$463M |
-$530M |
-$67.4M |
AIG, CNP, ABBV, GM, C
|
13F-HR |
2/11/2020, 04:05 PM |
Q3 2019 |
87 |
$3.56B |
+$730M |
-$923M |
-$193M |
CNP, ABBV, AIG, INTC, GM
|
13F-HR |
11/14/2019, 10:17 AM |
Q2 2019 |
92 |
$3.98B |
+$911M |
-$604M |
+$308M |
BIO, AIG, T, JPM, OXY
|
13F-HR |
8/13/2019, 01:40 PM |
Q1 2019 |
89 |
$4.14B |
|
|
|
DWDP, AIG, PFE, T, OXY
|
13F-HR |
5/13/2019, 12:24 PM |